Paget-Schroetter syndrome: Difference between revisions

No edit summary
 
Line 1: Line 1:
==Background==
==Background==
*Thrombosis of the axillary and/or subclavian vein associated with repetitive movements of the upper extremity, such as those with sporting events (e.g. swimming, wrestling, etc)<ref name="Alla">Alla, V. M., Natarajan, N., Kaushik, M., Warrier, R., & Nair, C. K. (2010). Paget-Schroetter Syndrome: Review of Pathogenesis and Treatment of Effort Thrombosis. Western Journal of Emergency Medicine, 11(4), 358–362.</ref>
*[[Thromboembolism|Thrombosis]] of the axillary and/or subclavian vein associated with repetitive movements of the upper extremity, such as those with sporting events (e.g. swimming, wrestling, etc)<ref name="Alla">Alla, V. M., Natarajan, N., Kaushik, M., Warrier, R., & Nair, C. K. (2010). Paget-Schroetter Syndrome: Review of Pathogenesis and Treatment of Effort Thrombosis. Western Journal of Emergency Medicine, 11(4), 358–362.</ref>
*Usually affects dominant arm
*Usually affects dominant arm
*May be acute, subacute or chronic
*May be acute, subacute or chronic
Line 6: Line 6:
==Clinical Features==
==Clinical Features==
*Arm swelling, pain
*Arm swelling, pain
*Redness of the upper extremity
*[[rash|Redness]] of the upper extremity
*Dilated, visible veins around the shoulder (Urschel’s sign)
*Dilated, visible veins around the shoulder (Urschel’s sign)
*Most patients report a precipitating event, generally sports-related arm exertion<ref name="Alla" />
*Most patients report a precipitating event, generally sports-related arm exertion<ref name="Alla" />
Line 14: Line 14:


==Evaluation==
==Evaluation==
*Doppler ultrasound is preferred test
*[[Ultrasound: DVT|Doppler ultrasound]] is preferred test
*CTV or MRV have higher sensitivity/specificity if continued clinical concern
*CTV or MRV have higher sensitivity/specificity if continued clinical concern
*May also consider:
*May also consider:
**[[CXR]] to evaluate for causes of thoracic outlet obstruction
**[[CXR]] to evaluate for causes of [[thoracic outlet obstruction]]
**Laboratory testing
**Laboratory testing


==Management==
==Management==
[[File:PSS.jpg|thumb|Paget-Schroetter syndrome treatment]]
[[File:PSS.jpg|thumb|Paget-Schroetter syndrome treatment]]
*Catheter-directed thrombolysis is first-line treatment for acute disease (<2-6 weeks duration)<ref name="Alla" />
*Catheter-directed [[thrombolysis]] is first-line treatment for acute disease (<2-6 weeks duration)<ref name="Alla" />
*Consider surgical thoracic outlet decompression (TOD) for chronic disease or failure of catheter-directed thrombolysis
*Consider surgical thoracic outlet decompression (TOD) for chronic disease or failure of catheter-directed thrombolysis
*'''Anticoagulation alone is not recommended due to high rates of morbidity'''
*'''Anticoagulation alone is not recommended due to high rates of morbidity'''

Latest revision as of 17:13, 1 October 2019

Background

  • Thrombosis of the axillary and/or subclavian vein associated with repetitive movements of the upper extremity, such as those with sporting events (e.g. swimming, wrestling, etc)[1]
  • Usually affects dominant arm
  • May be acute, subacute or chronic

Clinical Features

  • Arm swelling, pain
  • Redness of the upper extremity
  • Dilated, visible veins around the shoulder (Urschel’s sign)
  • Most patients report a precipitating event, generally sports-related arm exertion[1]

Differential Diagnosis

Upper extremity swelling

Evaluation

Management

Paget-Schroetter syndrome treatment
  • Catheter-directed thrombolysis is first-line treatment for acute disease (<2-6 weeks duration)[1]
  • Consider surgical thoracic outlet decompression (TOD) for chronic disease or failure of catheter-directed thrombolysis
  • Anticoagulation alone is not recommended due to high rates of morbidity

Disposition

  • Admit

See Also

References

  1. 1.0 1.1 1.2 Alla, V. M., Natarajan, N., Kaushik, M., Warrier, R., & Nair, C. K. (2010). Paget-Schroetter Syndrome: Review of Pathogenesis and Treatment of Effort Thrombosis. Western Journal of Emergency Medicine, 11(4), 358–362.